Medicalgorithmics Balance Sheet Health
Financial Health criteria checks 2/6
Medicalgorithmics has a total shareholder equity of PLN62.9M and total debt of PLN24.1M, which brings its debt-to-equity ratio to 38.4%. Its total assets and total liabilities are PLN111.4M and PLN48.4M respectively.
Key information
38.36%
Debt to equity ratio
zł24.14m
Debt
| Interest coverage ratio | n/a |
| Cash | zł2.57m |
| Equity | zł62.94m |
| Total liabilities | zł48.42m |
| Total assets | zł111.36m |
Recent financial health updates
Would Medicalgorithmics (WSE:MDG) Be Better Off With Less Debt?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Is Medicalgorithmics (WSE:MDG) A Risky Investment?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...These 4 Measures Indicate That Medicalgorithmics (WSE:MDG) Is Using Debt Reasonably Well
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...Is Medicalgorithmics (WSE:MDG) A Risky Investment?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Recent updates
Financial Position Analysis
Short Term Liabilities: MDG's short term assets (PLN17.2M) exceed its short term liabilities (PLN15.5M).
Long Term Liabilities: MDG's short term assets (PLN17.2M) do not cover its long term liabilities (PLN32.9M).
Debt to Equity History and Analysis
Debt Level: MDG's net debt to equity ratio (34.3%) is considered satisfactory.
Reducing Debt: MDG's debt to equity ratio has increased from 19.7% to 38.4% over the past 5 years.
Debt Coverage: MDG's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if MDG's interest payments on its debt are well covered by EBIT.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/09/09 05:35 |
| End of Day Share Price | 2026/09/09 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Medicalgorithmics S.A. is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Adrian Kowollik | East Value Research GmbH |
| Lukasz Kosiarski | Ipopema Securities S.A. |
| Gabriela Burdach | Wood & Company |